Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,015 | -59,457 | -45,878 | -55,423 | -29,830 |
| Depreciation Amortization | 3,701 | 15,321 | 11,414 | 7,525 | 3,773 |
| Accounts receivable | 2,050 | -8,646 | -3,102 | -2,566 | -1,864 |
| Other Working Capital | -6,295 | -57,767 | -55,316 | -21,448 | -16,143 |
| Other Operating Activity | 11,022 | 64,563 | 44,841 | 30,998 | 15,580 |
| Operating Cash Flow | $-9,537 | $-45,986 | $-48,041 | $-40,914 | $-28,484 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,939 | 40,909 | 48,525 | 30,833 | 26,832 |
| PPE Investments | -796 | -2,959 | -2,323 | -1,914 | -1,259 |
| Investing Cash Flow | $9,143 | $37,950 | $46,202 | $28,919 | $25,573 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,500 | 30,403 | 8,745 | 7,061 | 5,451 |
| Financing Cash Flow | $7,500 | $30,403 | $8,745 | $7,061 | $5,451 |
| Beginning Cash Position | 73,184 | 50,817 | 50,817 | 50,817 | 50,817 |
| End Cash Position | 80,290 | 73,184 | 57,723 | 45,883 | 53,357 |
| Net Cash Flow | $7,106 | $22,367 | $6,906 | $-4,934 | $2,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,537 | -45,986 | -48,041 | -40,914 | -28,484 |
| Capital Expenditure | -796 | -2,959 | -2,323 | -1,914 | -1,259 |
| Free Cash Flow | -10,333 | -48,945 | -50,364 | -42,828 | -29,743 |